Business Description
Pacific Shuanglin Bio-pharmacy Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000F14
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.21 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.71 | |||||
Interest Coverage | 93.19 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 11.24 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.2 | |||||
3-Year EBITDA Growth Rate | 25.8 | |||||
3-Year EPS without NRI Growth Rate | 33.1 | |||||
3-Year FCF Growth Rate | 9.4 | |||||
3-Year Book Growth Rate | 72.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.08 | |||||
9-Day RSI | 35.74 | |||||
14-Day RSI | 39.41 | |||||
6-1 Month Momentum % | 5.68 | |||||
12-1 Month Momentum % | 41.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.01 | |||||
Quick Ratio | 2.72 | |||||
Cash Ratio | 2.05 | |||||
Days Inventory | 281.33 | |||||
Days Sales Outstanding | 73.34 | |||||
Days Payable | 41.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.75 | |||||
Dividend Payout Ratio | 0.09 | |||||
3-Year Dividend Growth Rate | -12.6 | |||||
Forward Dividend Yield % | 0.75 | |||||
5-Year Yield-on-Cost % | 0.74 | |||||
3-Year Average Share Buyback Ratio | -14.2 | |||||
Shareholder Yield % | 0.05 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.79 | |||||
Operating Margin % | 29.62 | |||||
Net Margin % | 27.07 | |||||
FCF Margin % | 5.34 | |||||
ROE % | 9.42 | |||||
ROA % | 8.14 | |||||
ROIC % | 10.61 | |||||
ROC (Joel Greenblatt) % | 32.44 | |||||
ROCE % | 10.38 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 28.03 | |||||
PE Ratio without NRI | 27.85 | |||||
Shiller PE Ratio | 72.25 | |||||
Price-to-Owner-Earnings | 42.71 | |||||
PEG Ratio | 0.96 | |||||
PS Ratio | 7.52 | |||||
PB Ratio | 2.52 | |||||
Price-to-Tangible-Book | 4.1 | |||||
Price-to-Free-Cash-Flow | 137.78 | |||||
Price-to-Operating-Cash-Flow | 35.98 | |||||
EV-to-EBIT | 23.68 | |||||
EV-to-EBITDA | 23.68 | |||||
EV-to-Revenue | 7.32 | |||||
EV-to-FCF | 137.11 | |||||
Price-to-Projected-FCF | 2.5 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.13 | |||||
Price-to-Graham-Number | 2.28 | |||||
Price-to-Net-Current-Asset-Value | 8.47 | |||||
Price-to-Net-Cash | 32.52 | |||||
Earnings Yield (Greenblatt) % | 4.22 | |||||
FCF Yield % | 0.7 | |||||
Forward Rate of Return (Yacktman) % | 20.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pacific Shuanglin Bio-pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,503.505 | ||
EPS (TTM) (Â¥) | 0.928 | ||
Beta | 1.38 | ||
Volatility % | 36.88 | ||
14-Day RSI | 39.41 | ||
14-Day ATR (Â¥) | 0.92283 | ||
20-Day SMA (Â¥) | 27.8605 | ||
12-1 Month Momentum % | 41.73 | ||
52-Week Range (Â¥) | 17.49 - 31.25 | ||
Shares Outstanding (Mil) | 733.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pacific Shuanglin Bio-pharmacy Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pacific Shuanglin Bio-pharmacy Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Pacific Shuanglin Bio-pharmacy Co Ltd Frequently Asked Questions
What is Pacific Shuanglin Bio-pharmacy Co Ltd(SZSE:000403)'s stock price today?
When is next earnings date of Pacific Shuanglin Bio-pharmacy Co Ltd(SZSE:000403)?
Does Pacific Shuanglin Bio-pharmacy Co Ltd(SZSE:000403) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |